In a retrospective analysis, researchers compared survival outcomes and prognostic factors between patients with advanced-stage epithelial ovarian cancer who underwent hyperthermic intraperitoneal...
A retrospective cohort study compared the patient characteristics and postoperative outcomes of those with stage III or IV epithelial ovarian cancer who had same-day discharge following minimally invasive...
New findings from the Women’s Health Initiative trials provide long-term insights into the effects of hormone therapy regimens on ovarian and endometrial cancer incidence and mortality.
Researchers evaluated the response rate of gemcitabine in patients with platinum-resistant ovarian cancer given at a low dosage. Their research was presented at the Hematology/Oncology Pharmacy...
The US Food and Drug Administration granted regular approval to a maintenance therapy for adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
